Wal-Act
- RxCUI
- 1014651
- RxNorm name
- Wal-Act
- Term type
- BN
- Status
- Active
- Updated
- 2026-07-27 06:53:12
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 112010
- Active start
- 112010
- Multiple ingredient
- YES
- Branded
- YES
Derived Ingredient Concepts#
Source Vocabulary Codes#
Code type, Value, Category table| Code type | Value | Category |
|---|
| PRESCRIBABLE | Y | ATTRIBUTES |
| RXNAV_STR | Wal-Act | NAMES |
| RxNorm Name | Wal-Act | NAMES |
| TTY | BN | ATTRIBUTES |
| RxCUI | 1014651 | CODES |
| MMSL_CODE | BN176109 | CODES |
Drug Classes#
Source, Class ID, Class table| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|
| ATC | R06AX | Other antihistamines for systemic use | ATC1-4 | | triprolidine |
| ATC | R01BA | Sympathomimetics | ATC1-4 | | pseudoephedrine |
| FDASPL | N0000175552 | alpha-Adrenergic Agonist | EPC | has_epc | pseudoephedrine |
| MEDRT | D054199 | Pseudoephedrine | CHEM | has_ingredient | pseudoephedrine |
| MEDRT | D054199 | Pseudoephedrine | CHEM | has_ingredient | pseudoephedrine hydrochloride |
| MEDRT | D014311 | Triprolidine | CHEM | has_ingredient | triprolidine hydrochloride |
| MEDRT | D014311 | Triprolidine | CHEM | has_ingredient | triprolidine |
| MEDRT | D001249 | Asthma | DISEASE | may_treat | pseudoephedrine |
| MEDRT | D001249 | Asthma | DISEASE | may_treat | pseudoephedrine hydrochloride |
| MEDRT | D003139 | Common Cold | DISEASE | may_treat | pseudoephedrine hydrochloride |
| MEDRT | D003139 | Common Cold | DISEASE | may_treat | pseudoephedrine |
| MEDRT | D003233 | Conjunctivitis, Allergic | DISEASE | may_treat | triprolidine hydrochloride |
| MEDRT | D003233 | Conjunctivitis, Allergic | DISEASE | may_treat | triprolidine |
| MEDRT | D003327 | Coronary Disease | DISEASE | ci_with | triprolidine hydrochloride |
| MEDRT | D003327 | Coronary Disease | DISEASE | ci_with | triprolidine |
| MEDRT | D003876 | Dermatitis, Atopic | DISEASE | may_treat | triprolidine hydrochloride |
| MEDRT | D003876 | Dermatitis, Atopic | DISEASE | may_treat | triprolidine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | pseudoephedrine hydrochloride |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | pseudoephedrine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | triprolidine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | triprolidine hydrochloride |
| MEDRT | D012220 | Rhinitis | DISEASE | may_treat | triprolidine hydrochloride |
| MEDRT | D012220 | Rhinitis | DISEASE | may_treat | triprolidine |
| MEDRT | D012221 | Rhinitis, Allergic, Perennial | DISEASE | may_treat | pseudoephedrine |
| MEDRT | D012221 | Rhinitis, Allergic, Perennial | DISEASE | may_treat | pseudoephedrine hydrochloride |
| MEDRT | D012852 | Sinusitis | DISEASE | may_treat | pseudoephedrine |
| MEDRT | D012852 | Sinusitis | DISEASE | may_treat | pseudoephedrine hydrochloride |
| MEDRT | N0000000209 | Adrenergic alpha-Agonists | MOA | has_moa | pseudoephedrine hydrochloride |
| MEDRT | N0000000209 | Adrenergic alpha-Agonists | MOA | has_moa | pseudoephedrine |
| MEDRT | N0000000245 | Adrenergic beta-Agonists | MOA | has_moa | pseudoephedrine |
| MEDRT | N0000000245 | Adrenergic beta-Agonists | MOA | has_moa | pseudoephedrine hydrochloride |
| MEDRT | N0000000190 | Histamine H1 Receptor Antagonists | MOA | has_moa | triprolidine hydrochloride |
| MEDRT | N0000000190 | Histamine H1 Receptor Antagonists | MOA | has_moa | triprolidine |
| MEDRT | N0000000184 | Monoamine Oxidase Inhibitors | MOA | ci_moa | triprolidine |
| MEDRT | N0000000184 | Monoamine Oxidase Inhibitors | MOA | ci_moa | pseudoephedrine |
| MEDRT | N0000000184 | Monoamine Oxidase Inhibitors | MOA | ci_moa | triprolidine hydrochloride |
| MEDRT | N0000000184 | Monoamine Oxidase Inhibitors | MOA | ci_moa | pseudoephedrine hydrochloride |
| MEDRT | N0000008322 | Bronchodilation | PE | has_pe | pseudoephedrine hydrochloride |
| MEDRT | N0000008322 | Bronchodilation | PE | has_pe | pseudoephedrine |
| MEDRT | N0000008657 | Decreased Histamine Activity | PE | has_pe | triprolidine |
| MEDRT | N0000008657 | Decreased Histamine Activity | PE | has_pe | triprolidine hydrochloride |
| MEDRT | N0000009908 | Vasoconstriction | PE | has_pe | pseudoephedrine |
| MEDRT | N0000009908 | Vasoconstriction | PE | has_pe | pseudoephedrine hydrochloride |
Properties#
Category, Property, Value table| Category | Property | Value |
|---|
| ATTRIBUTES | BN_CARDINALITY | multi |
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| ATTRIBUTES | PRESCRIBABLE | Y |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | TTY | BN |
| CODES | MMSL_CODE | BN176109 |
| CODES | RxCUI | 1014651 |
| NAMES | RXNAV_STR | Wal-Act |
| NAMES | RxNorm Name | Wal-Act |
| SOURCES | Source | Multum MediSource Lexicon |